Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Hum Mutat. 2018 Jan 16;39(4):471–494. doi: 10.1002/humu.23395

Table 3.

MAF human mutations

Nuc. Pos. AA Pos. Vt AD/
AR
Prot.
Func.
AA
Con
.
Pat
ho.
Ap C C
o
F
c
G H C
o
l
M
c
M
t
N
y
P
a
Sy Pat. Info. Ref.
c.161C>T p.Ser54Leu ms NA Pre-d y m n y n y n y n n n n n Ayme-Gripp Proband (age 39 years, female (Aymé and Philip, 1996; Niceta et al., 2015)
c.161C>T p.Ser54Leu ms NA Pre-d y m n y n y n y n n n n n Ayme-Gripp Proband (age 43 years, female) (Niceta et al., 2015)
c.172A>G p.Thr58Ala ms NA Pre-d y m n y n y n y n n n n n Ayme-Gripp Proband (age 27 years, female (Gripp et al., 1996; Niceta et al., 2015)
c.173C>T p.Thr58Ile ms NA Pre-d y m n y n y n y n n n n n Ayme-Gripp Proband (age 22 monthss, male) (Nakane et al., 2002; Niceta et al., 2015)
c.176C>G p.Pro59Arg ms NA Pre-d y m y y, cg, nu n y y y n n n n n Asperger Proband (Javadiyan et al., 2017)
c.176C>G p.Pro59Arg ms NA Pre-d y m n y n y n y n n n n n n Mother of proband
c.176C>A p.Pro59His ms NA Pre-d y m n y n y n y n n n n n Ayme-Gripp Proband (age 9 years, female) (Keppler-Noreuil et al., 2007; Niceta et al., 2015)
c.176C>A p.Pro59His ms NA Pre-d y m n y n y n y n n n n n Ayme-Gripp Proband (age 5 years, female) (Niceta et al., 2015)
c.185C>G p.Thr62Arg ms NA Pre-d y m n y n y n y n n n n n Ayme-Gripp Proband (age 21 months, male) (Niceta et al., 2015)
c.206C>G p.Pro69Arg ms NA Pre-d y m n y n y n y n n n n n Ayme-Gripp Proband (age 21 months, male) (Gripp et al., 1996; Niceta et al., 2015)
c.809C>A p.Ser270Tyr ms AD Pre-d y m n y, nu n n n n n y n y n n Proband (Dudakova et al., 2017)
c.809C>A p.Ser270Tyr ms AD Pre-d y m n y, cg, nu n n n n n y n y n n Half brother of proband
c.819G>C p.Glu273Asp ms AD Pre-d y m n y, cr n n n n n n n n n n Two affected family members (father and son) (Ma et al., 2016)
c.864G>C p.Arg288Pro ms AD nr y m n y, ct, nu n n n n y y n n n n Two affected family members (Jamieson et al., 2002)
c.880C>T p.Arg294Trp ms AD Pre-d y m n y, cg n n n n n n n n n n Probands from thirty families (Ma et al., 2016)
c.880C>T p.Arg294Trp ms AD Pre-d y m n y, nu n n n n n n n y n n Seven affected family members (Sun et al., 2014)
c.890A>G p.Lys297Arg ms AD nr y m n y, cr n n n n n n n n n n Proband (8 years age) (Vanita et al., 2006)
c.890A>G p.Lys297Arg ms AD nr y m n y n n n n n n n n n n Five affected family members
c.890A>G p.Lys297Arg ms AD nr y m n y n n n n y y n n n n Six affected family members
c.895C>A p. Arg299Ser ms NA nr y m n y, cg, po, nu n n n n y n n n n n Four affected family members (Hansen et al., 2007, 2009)
c.908A>C p.Gln303Leu ms NA Pre-d y m n y, cg n n n n n n n n n n Proband (Narumi et al., 2014)
c.908A>C p.Gln303Leu ms NA Pre-d y m n y, cg n n n n n n n n n n Mother of proband
c.908A>C p.Gln303Leu ms NA Pre-d y m n y n n n n n n n n n n Maternal grandmother of proband
c.908A>C p.Gln303Leu ms NA Pre-d y m n y, la n n n n y y n n n n First maternal cousin of proband
c.908A>C p.Gln303Leu ms NA Pre-d y m n y, nu n n y n n n n n n n Second maternal cousin of proband
c.908A>C p.Gln303Leu ms NA Pre-d y m n y n n n n n y n n n n Mother and sister of second maternal cousin of proband
c.915C>T p.Cys305Trp ms AD Pre-d y m n y, cg n n y n n n n n n n Proband (Ma et al., 2016)
c.958A>G p.Lys320Glu ms NA nr y m n y, cg n n n n n n n n n n Proband (Hansen et al., 2009)
c.958A>G p.Lys320Glu ms NA nr y m n n n n n n n y n n n n One affected family member
t(5;16)(p15.3;q23.2) - - NA nr y m n y n n n n n n n n n n Two affected family member (Jamieson et al., 2002)
t(5;16)(p15.3;q23.2) - - NA nr y m n y, cg y n n n y n y n y n Other affected family members

Notes: NA, not reported in original article; Nuc. Pos., nucleotide position in CDS; AA Pos., amino acid position; Vt, variant type; fs, frameshift; ms, missense; ns, nonsense; nt, nonstop; AD, autosomal dominant; AR, autosomal recessive; NA, not available; Prot. Func, protein function; nr, not reported; Pre-d, predicted- damaging; n, no; y, yes; AA con., amino acid conservation; Patho., pathogenicity; m, maybe pathogenic; Ap, Aphakia; C, Cataract; cr, cerulean; cg, congenital; ct, cortical; la, lamellar; nu, nuclear; po, polar; Co, Corneal opacity/abnormal cornea; Fc, Facial characteristics; G, Glaucoma; H, Hearing loss; Col, Iris coloboma/coloboma/abnormal iris; Mc, Microcornea; Mt, Microphthalmia; Ny, Nystagmus; Pa, Peters anomaly; Sy, Syndrome; Pt. Info., patient information; Ref., reference